The immunomodulatory effects of rolipram abolish drug-resistant latent phase of Toxoplasma gondii infection in a murine model

BACKGROUND: Latent toxoplasmosis always has the risk of reactivation leading to significant sequelae. The available medications, for chronic toxoplasmosis, are awfully limited by resistance of Toxoplasma cysts. Therefore, there is a growing necessity for novel therapeutic approaches. Agents increasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Afifi, Mohammed A., Al-Rabia, Mohammed W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014187/
https://www.ncbi.nlm.nih.gov/pubmed/30023187
http://dx.doi.org/10.1016/j.jmau.2014.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014187/
https://www.ncbi.nlm.nih.gov/pubmed/30023187
http://dx.doi.org/10.1016/j.jmau.2014.12.001

Ejemplares similares